Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
Amgen-backed quantum computing firm plans IPO
A quantum tech firm that has collaborated with—and received investment from—Amgen is now planning to go public.
James Waldron
May 10, 2026 8:25am
Blackstone Invests $250M in Anagram to reduce CF pill burden
May 7, 2026 10:36am
CellCentric raises $220M to advance myeloma drug
May 6, 2026 7:00am
Fierce Biotech Fundraising Tracker '26: Cytospire & more
May 5, 2026 10:15am
Rebranded biotech lands $125M for rescued Galapagos assets
Apr 28, 2026 7:00am
British biotech funding‘s ‘signs of recovery,’ but still no IPOs
Apr 27, 2026 6:59am
